Home
HUMA
HUMA News

Latest Humacyte Inc. (HUMA) News on January 22, 2025

Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

GlobeNewswire

9 days ago

Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Humacyte price target raised to $17 from $15 at Benchmark

TipRanks

a month ago

Humacyte price target raised to $17 from $15 at Benchmark

High Growth Tech Stocks to Watch in December 2024

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in December 2024

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

GlobeNewswire

a month ago

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Individual investors who have a significant stake must be disappointed along with institutions after Humacyte, Inc.'s (NASDAQ:HUMA) market cap dropped by US$60m

Simply Wall St.

a month ago

Individual investors who have a significant stake must be disappointed along with institutions after Humacyte, Inc.'s (NASDAQ:HUMA) market cap dropped by US$60m

Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire

2 months ago

Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference

Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)

GlobeNewswire

2 months ago

Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)

Insider Buyers At Humacyte Likely Disappointed With 17% Slide

Simply Wall St.

2 months ago

Insider Buyers At Humacyte Likely Disappointed With 17% Slide

Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

GlobeNewswire

2 months ago

Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

Humacyte Presents Preclinical Results of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024

GlobeNewswire

2 months ago

Humacyte Presents Preclinical Results of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024

Humacyte Announces Pricing of $15.0 Million Registered Direct Offering

GlobeNewswire

2 months ago

Humacyte Announces Pricing of $15.0 Million Registered Direct Offering

Humacyte Third Quarter 2024 Financial Results and Business Update

GlobeNewswire

2 months ago

Humacyte Third Quarter 2024 Financial Results and Business Update

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 8, 2024

GlobeNewswire

3 months ago

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 8, 2024

Humacyte Announces Presentation of Positive Results from V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024

GlobeNewswire

3 months ago

Humacyte Announces Presentation of Positive Results from V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks to Watch in October 2024

Humacyte to Host Virtual KOL Event on the Use of Acellular Tissue Engineered Vessel (ATEV™) for AV Access in Hemodialysis on October 31, 2024

GlobeNewswire

3 months ago

Humacyte to Host Virtual KOL Event on the Use of Acellular Tissue Engineered Vessel (ATEV™) for AV Access in Hemodialysis on October 31, 2024

‘It’s Spare Parts for People’: Blood Vessels Grown in a Lab

The Wall Street Journal

3 months ago

‘It’s Spare Parts for People’: Blood Vessels Grown in a Lab

Humacyte Late-Breaking Abstract Accepted for Oral Presentation on V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024

GlobeNewswire

3 months ago

Humacyte Late-Breaking Abstract Accepted for Oral Presentation on V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024

Humacyte Launches $30M Stock and Warrants Offering

TipRanks

3 months ago

Humacyte Launches $30M Stock and Warrants Offering

Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

GlobeNewswire

4 months ago

Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024

GlobeNewswire

4 months ago

Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks in the United States

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)

GlobeNewswire

4 months ago

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)

Humacyte to Participate at Upcoming Investor Conferences in September

GlobeNewswire

5 months ago

Humacyte to Participate at Upcoming Investor Conferences in September

Humacyte Presents Positive Long-Term Results of ATEV™ in Treatment of Vascular Trauma in Military Setting from Ukraine Humanitarian Program

GlobeNewswire

5 months ago

Humacyte Presents Positive Long-Term Results of ATEV™ in Treatment of Vascular Trauma in Military Setting from Ukraine Humanitarian Program

Humacyte Second Quarter 2024 Financial Results and Business Update

GlobeNewswire

5 months ago

Humacyte Second Quarter 2024 Financial Results and Business Update

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 13, 2024

GlobeNewswire

5 months ago

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 13, 2024

Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma

GlobeNewswire

5 months ago

Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma

Companies Like Humacyte (NASDAQ:HUMA) Are In A Position To Invest In Growth

Simply Wall St.

6 months ago

Companies Like Humacyte (NASDAQ:HUMA) Are In A Position To Invest In Growth

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Meets Primary Endpoints in V007 Phase 3 Clinical Trial in Arteriovenous Access for Hemodialysis

GlobeNewswire

6 months ago

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Meets Primary Endpoints in V007 Phase 3 Clinical Trial in Arteriovenous Access for Hemodialysis

Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones

GlobeNewswire

6 months ago

Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs

Business Wire

6 months ago

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs

While institutions own 20% of Humacyte, Inc. (NASDAQ:HUMA), individual investors are its largest shareholders with 50% ownership

Simply Wall St.

7 months ago

While institutions own 20% of Humacyte, Inc. (NASDAQ:HUMA), individual investors are its largest shareholders with 50% ownership

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)

GlobeNewswire

7 months ago

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)

Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program

GlobeNewswire

7 months ago

Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program

Centers for Medicare & Medicaid Services (CMS) Issues ICD-10-PCS Codes for Humacyte’s Human Acellular Vessel™ (HAV™)

GlobeNewswire

7 months ago

Centers for Medicare & Medicaid Services (CMS) Issues ICD-10-PCS Codes for Humacyte’s Human Acellular Vessel™ (HAV™)

This Is Why Humacyte, Inc.'s (NASDAQ:HUMA) CEO Compensation Looks Appropriate

Simply Wall St.

8 months ago

This Is Why Humacyte, Inc.'s (NASDAQ:HUMA) CEO Compensation Looks Appropriate

Insider Sale: COO Heather Prichard Divests All Shares in Humacyte Inc (HUMA)

GuruFocus.com

8 months ago

Insider Sale: COO Heather Prichard Divests All Shares in Humacyte Inc (HUMA)

Humacyte to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

8 months ago

Humacyte to Present at the Jefferies Global Healthcare Conference

This Humacyte Insider Increased Their Holding By 91% Last Year

Simply Wall St.

8 months ago

This Humacyte Insider Increased Their Holding By 91% Last Year

Humacyte to Participate at Upcoming Investor Conferences in May

GlobeNewswire

8 months ago

Humacyte to Participate at Upcoming Investor Conferences in May

GuruFocus.com

8 months ago

Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances

Humacyte First Quarter 2024 Financial Results and Business Update

GlobeNewswire

8 months ago

Humacyte First Quarter 2024 Financial Results and Business Update

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024

GlobeNewswire

9 months ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024

Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024

GlobeNewswire

10 months ago

Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024

Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript

Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update

GlobeNewswire

10 months ago

Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update

Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024

GlobeNewswire

10 months ago

Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024

Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

a year ago

Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference

Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock

GlobeNewswire

a year ago

Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire

a year ago

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

GlobeNewswire

a year ago

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

OneWater's (NASDAQ:ONEW) Q1 Earnings Results: Revenue In Line With Expectations, Stock Soars

StockStory

a year ago

OneWater's (NASDAQ:ONEW) Q1 Earnings Results: Revenue In Line With Expectations, Stock Soars

Oculis to Present at Upcoming February Investor Conferences

GlobeNewswire

a year ago

Oculis to Present at Upcoming February Investor Conferences

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/29/2024

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 01/29/2024

Elias Sabo Bought 15% More Shares In Compass Diversified

Simply Wall St.

a year ago

Elias Sabo Bought 15% More Shares In Compass Diversified

Alector (ALEC) Upgraded to Strong Buy: Here's What You Should Know

Zacks

a year ago

Alector (ALEC) Upgraded to Strong Buy: Here's What You Should Know

RBB Bancorp (NASDAQ:RBB) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

RBB Bancorp (NASDAQ:RBB) Q4 2023 Earnings Call Transcript

Gear Up for Washington Trust (WASH) Q4 Earnings: Wall Street Estimates for Key Metrics

Zacks

a year ago

Gear Up for Washington Trust (WASH) Q4 Earnings: Wall Street Estimates for Key Metrics

One OneSpan Insider Raised Stake By 13% In Previous Year

Simply Wall St.

a year ago

One OneSpan Insider Raised Stake By 13% In Previous Year

Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call

GlobeNewswire

a year ago

Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

Zacks

a year ago

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

Southern First Bancshares Inc (SFST) Reports Earnings for Q4 and Full Year 2023

GuruFocus.com

a year ago

Southern First Bancshares Inc (SFST) Reports Earnings for Q4 and Full Year 2023

Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics

Motley Fool

a year ago

Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics

Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?

Zacks

a year ago

Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?

eXp Luxury Solidifies Expansion Into New International Markets

GlobeNewswire

a year ago

eXp Luxury Solidifies Expansion Into New International Markets

How Allogene (ALLO) Stock Stands Out in a Strong Industry

Zacks

a year ago

How Allogene (ALLO) Stock Stands Out in a Strong Industry

Wolverine Worldwide Sells Sperry

Business Wire

a year ago

Wolverine Worldwide Sells Sperry

Real Makes It Easier For Independent Brokerages and Team Leaders to Align with the Nation’s Fastest Growing Brokerage

Business Wire

a year ago

Real Makes It Easier For Independent Brokerages and Team Leaders to Align with the Nation’s Fastest Growing Brokerage

After Plunging -16.4% in 4 Weeks, Here's Why the Trend Might Reverse for Forge Global Holdings, Inc. (FRGE)

Zacks

a year ago

After Plunging -16.4% in 4 Weeks, Here's Why the Trend Might Reverse for Forge Global Holdings, Inc. (FRGE)

CI&T Releases 2024 Connected Retail Report

Business Wire

a year ago

CI&T Releases 2024 Connected Retail Report

TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares

GlobeNewswire

a year ago

TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Business Wire

a year ago

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Entravision Announces Massive Expansion of Spanish-Language News Coverage

Business Wire

a year ago

Entravision Announces Massive Expansion of Spanish-Language News Coverage

Cambridge Bancorp Sets Fourth Quarter 2023 Earnings Release Date

PR Newswire

a year ago

Cambridge Bancorp Sets Fourth Quarter 2023 Earnings Release Date

Reuters

a year ago

UPDATE 5-'Oppenheimer' triumphs at Golden Globes as Hollywood parties again

Voyager Therapeutics Announces Pricing of Public Offering

GlobeNewswire

a year ago

Voyager Therapeutics Announces Pricing of Public Offering

Tanger Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

PR Newswire

a year ago

Tanger Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference

Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California

GlobeNewswire

a year ago

Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California

Why We Like The Returns At Encore Wire (NASDAQ:WIRE)

Simply Wall St.

a year ago

Why We Like The Returns At Encore Wire (NASDAQ:WIRE)

Shareholders in Universal Insurance Holdings (NYSE:UVE) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in Universal Insurance Holdings (NYSE:UVE) are in the red if they invested five years ago

Terex (TEX) Gains 40% in a Year: Will the Rally Last in 2024?

Zacks

a year ago

Terex (TEX) Gains 40% in a Year: Will the Rally Last in 2024?

Time to Buy These Top-Rated Security and Safety Services Stocks

Zacks

a year ago

Time to Buy These Top-Rated Security and Safety Services Stocks

Here’s Why Diamond Hill Long-Short Fund Initiated a Short Position in Alarm.com Holdings (ALRM)

Insider Monkey

a year ago

Here’s Why Diamond Hill Long-Short Fund Initiated a Short Position in Alarm.com Holdings (ALRM)

Nerdy Inc. (NRDY) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

Nerdy Inc. (NRDY) Upgraded to Buy: What Does It Mean for the Stock?

Forge Bolsters Roster with Strategic Hires to Deliver Greater Value to Private Company Partners, Institutional Investors

Business Wire

a year ago

Forge Bolsters Roster with Strategic Hires to Deliver Greater Value to Private Company Partners, Institutional Investors

Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023

GlobeNewswire

a year ago

Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023

KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology

Business Wire

a year ago

KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology

There's Reason For Concern Over Cars.com Inc.'s (NYSE:CARS) Price

Simply Wall St.

a year ago

There's Reason For Concern Over Cars.com Inc.'s (NYSE:CARS) Price

The past three years for Johnson Outdoors (NASDAQ:JOUT) investors has not been profitable

Simply Wall St.

a year ago

The past three years for Johnson Outdoors (NASDAQ:JOUT) investors has not been profitable

BrightSpire Capital Announces $0.20 Per Share Dividend for Fourth Quarter 2023

Business Wire

a year ago

BrightSpire Capital Announces $0.20 Per Share Dividend for Fourth Quarter 2023

How to Boost Your Portfolio with Top Transportation Stocks Set to Beat Earnings

Zacks

a year ago

How to Boost Your Portfolio with Top Transportation Stocks Set to Beat Earnings

iHeartMedia and Empire State Building To Host "iHeartRadio Holiday Pop Up Party with Jimmy Fallon Presented by State Farm®" with Special Music-to-Light Show

Business Wire

a year ago

iHeartMedia and Empire State Building To Host "iHeartRadio Holiday Pop Up Party with Jimmy Fallon Presented by State Farm®" with Special Music-to-Light Show

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

GlobeNewswire

a year ago

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

Matterport's Annual ESG Report Highlights the Importance of its Digital Twin Technology in Reducing Carbon Footprint

GlobeNewswire

a year ago

Matterport's Annual ESG Report Highlights the Importance of its Digital Twin Technology in Reducing Carbon Footprint

Hackett Group (NASDAQ:HCKT) Has Affirmed Its Dividend Of $0.11

Simply Wall St.

a year ago

Hackett Group (NASDAQ:HCKT) Has Affirmed Its Dividend Of $0.11

MeridianLink Product Innovator Named as National Mortgage Professional 40 Under 40 Winner

Business Wire

a year ago

MeridianLink Product Innovator Named as National Mortgage Professional 40 Under 40 Winner

Share on Social Networks: